XTR003 PET Radiotracer for the Detection of Viable Myocardium
Status:
Completed
Trial end date:
2023-03-05
Target enrollment:
Participant gender:
Summary
The study was designed to explore the clinical feasibility of XTR003, a PET myocardial
fatty-acid tracer, for the detection of viable myocardium in patients with ischemic heart
disease (IHD).